Cargando…
Insights into the Management of Overactive Bladder with Transdermal Oxybutynin: A Practical Review
Overactive bladder (OAB), clinically defined as urinary urgency, with or without incontinence, generally accompanied by an increase in urinary frequency and nocturia, after any local disease or metabolic disorder that would explain these symptoms have been ruled out, is a highly prevalent condition...
Autores principales: | Vozmediano-Chicharro, Raúl, Blasco Hernández, Pedro, Madurga-Patuel, Blanca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434563/ https://www.ncbi.nlm.nih.gov/pubmed/32884926 http://dx.doi.org/10.2147/RRU.S266400 |
Ejemplares similares
-
Efficacy of Transdermal Oxybutynin in the Treatment of Overactive Bladder Syndrome: Does It Make Sense Using It in 2017?
por: Vozmediano-Chicharro, Raúl, et al.
Publicado: (2018) -
Transdermal oxybutynin in the treatment of overactive bladder
por: Davila, G Willy
Publicado: (2006) -
Clinical and Economic Evaluation of Transdermal Oxybutynin in the Treatment of Overactive Bladder in Spain
por: Crespo, Carlos, et al.
Publicado: (2018) -
Patient perspectives in the management of overactive bladder, focus on transdermal oxybutynin
por: Gamble, Tondalaya, et al.
Publicado: (2008) -
Clinical utility of transdermal delivery of oxybutynin gel via a metered-dose pump in the management of overactive bladder
por: Wagg, Adrian
Publicado: (2012)